An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance

• Sponsor: Robin, Alan L., M.D. (Other)
• Overall Status: Completed
• CT.gov ID: NCT00329095
• Collaborator: (none)
• Enrollment: 60
• Duration (Months): 4

Study Details

Study Description

Brief Summary

This is an open-label study in patients who are currently using either a topical prostaglandin as sole ocular hypotensive medical therapy q.d., or a topical prostaglandin plus an adjunctive topical ocular hypotensive marketed product either q.d., or b.i.d. in the same eye(s). Compliance will be measured over the two months of participation.

Condition or Disease	Intervention/Treatment	Phase
Glaucoma; Ocular Hypertension	Drug: travoprost, latanoprost, or bimatoprost; Drug: Additional ocular hypotensive medication	Phase 4

Detailed Description

This is an open-label study in patients who are currently using either a topical prostaglandin as sole ocular hypotensive medical therapy q.d., or a topical prostaglandin plus an adjunctive topical ocular hypotensive marketed product either q.d., or b.i.d. in the same eye(s). Compliance will be measured over the two months of participation.

Study Design

• Study Type: Interventional
• Allocation: Non-Randomized
• Intervention Model: Parallel Assignment
• Masking: None (Open Label)
• Primary Purpose: Diagnostic
• Official Title: An Evaluation of Use of Topical Ocular Hypotensive Medication by Electronic Compliance Measures
• Study Start Date: Dec 1, 2005
• Study Completion Date: Apr 1, 2006

Outcome Measures

Primary Outcome Measures

1. Compliance. []

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Currently using one or two topical ocular hypotensive medications

Exclusion Criteria:

• Hypersensitivity to any component of medication

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• Robin, Alan L., M.D.

Investigators

• Principal Investigator: Alan L. Robin, MD, Alan L. Robin, M.D.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• ClinicalTrials.gov Identifier: NCT00329095
• Other Study ID Numbers: GMED-01
• First Posted: May 24, 2006
• Last Update Posted: May 24, 2006
• Last Verified: May 1, 2006

• Keywords provided by , ,: Glaucoma; Compliance
• Additional relevant MeSH terms: Glaucoma; Ocular Hypertension; Bimatoprost; Travoprost; Antihypertensive Agents; Latanoprost

Study Results

No Results Posted as of May 24, 2006